However, different CDK activities and cyclins in driving cancer cell cycles are highly heterogeneous and can explain why some metastatic breast cancer patients can initially express high estrogen receptors, during which time they can turn into different expressions of estrogen/progesterone features, thus transforming from Luminal A to Luminal B. [25,26]. This evidence concerns the gene ESR1 and cancer.